Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.
- Shared decision making in oncology practice: what do oncologists need to know? Politi MC, Studts JL, Hayslip JW. Oncologist 17(1):91-100, 2012.
- "Providers practice prevention": promoting dental hygienists' use of evidence-based treatment of tobacco use and dependence. Studts JL, Burris JL, Kearns DK, Worth CT, Sorrell CL. J Dent Educ 73(9):1069-82, 2009.
- Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Sephton SE, Salmon P, Weissbecker I, Ulmer C, Floyd A, Hoover K, Studts JL. Arthritis Rheum 57(1):77-85, 2007.
- Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer. Studts JL, Abell TD, Roetzer LM, Albers AN, McMasters KM, Chao C. Psychooncology 14(8):647-60, 2005.
- Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making. Chao C, Studts JL, Abell T, Hadley T, Roetzer L, Dineen S, Lorenz D, YoussefAgha A, McMasters KM. J Clin Oncol 21(23):4299-305, 2003.
Cancer Center Member
Dr. Studts is a licensed clinical health psychologist, an Associate Professor in the Department of Behavioral Science at the University of Kentucky College of Medicine, and an active member of the Cancer Prevention and Control Program within the Markey Cancer Center.
His primary research interests involve examining behavioral and psychosocial factors associated with cancer prevention and control of tobacco-related malignancy. He has received research funding from the NCI, NIEHS, NIDCR, NIDA, and the National Center on Minority Health and Health Disparities. His currently funded research addresses the development of optimal smoking cessation interventions for individuals diagnosed with lung or head/neck cancer (KLCRP), efforts to promote informed decision making about lung cancer screening (NCI), testing an intervention to promote lung cancer prevention via radon risk notification (NIEHS), and the development of point-of-care software tools to facilitate implementation of evidence-based tobacco cessation strategies among a broad range of health care providers (NIDCR, NIDA). Although his training centered on cancer survivorship research, his interests have evolved into a focus on patient and provider decision making and efforts to develop interventions designed to facilitate informed and shared decision making regarding complex healthcare choices.
In addition to his work with the Markey Cancer Prevention and Control Program, he is actively involved in the education and training mission of the NIH-funded University of Kentucky Center for Clinical and Translational Science, where he serves as a member of the training faculty and the course director for Interdisciplinary Protocol Development, a course that combines training in preparing NIH grants and promoting interdisciplinary team science. His teaching and mentoring efforts were recently recognized with an Abraham Flexner Award for Educational Innovation and Curriculum Development by the UK Center for Excellence in Medical Education, and the Mentor Recognition Award from the UK Center for Clinical and Translational Science, respectively.
In terms of service to the scientific community, Dr. Studts is an active NIH reviewer and has been nominated to serve as a standing member of the Psychosocial Risk and Disease Prevention Study Section. Additionally, he currently serves as Chair of the Quality of Life Review Panel for the Canadian Cancer Society Research Institute.